Cardiol Therapeutics Inc. Current Derivative Financial Liabilities
Cardiol Therapeutics Inc. (CRDL) had Current Derivative Financial Liabilities of CAD 2.14 million as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Derivative Instruments and Hedging Activities
ifrs-full:CurrentDerivativeFinancialLiabilities · last filed 2026-03-31
- 2025-12-31: Current Derivative Financial Liabilities 2.14M CAD.
- 2023-12-31: Current Derivative Financial Liabilities 238.18K CAD.
- 2022-12-31: Current Derivative Financial Liabilities 419.90K CAD.
- 2021-12-31: Current Derivative Financial Liabilities 6.66M CAD.
| Period end | Current Derivative Financial Liabilities |
|---|---|
| 2025-12-31 | 2.14M CAD 40-F · filed 2026-03-31 |
| 2023-12-31 | 238.18K CAD 40-F · filed 2025-03-31 |
| 2022-12-31 | 419.90K CAD 20-F · filed 2024-04-01 |
| 2021-12-31 | 6.66M CAD 20-F · filed 2023-03-29 |